探讨头饱哌酮舒巴坦在下呼吸道感染临床治疗中的临床效果.docxVIP

探讨头饱哌酮舒巴坦在下呼吸道感染临床治疗中的临床效果甘南县屮医院162100摘要：目的：研究分析头饱哌酮/舒巴坦治疗下呼吸道感染的疗效及耐药趋势。方法：此次研究的对彖是选取某院收治的120例下呼吸道感染患者，将其临床资料进行回顾性分析，并在患者知情同意下由临床医师采取等距随机抽样法分为观察组和对照组。给予给予对照组患者釆用罗红霉素药物进行临床治疗，给予观察组患者采用头孑包哌酮/舒巴坦药物进行治疗。结果：观察组总有效例数为58例, 占比96.66%O对照组总有效例数为45例，占比75.00%。观察组与对照组在总有效例数上的差异具有统计学意义(Plt;0.05)。结论：针对下呼吸道感染患者，采用头抱哌酮/舒巴坦进行治疗，能够使临床症状得到有效的缓解，提高耐药性，可以在医学临床屮广泛应用。关键词：下呼吸道感染头孑包哌酮舒巴坦[Abstract] Objective： To study the curative effect and drug resista nee of the first full ? and - / - and ? respiratory tract infections in the treatment of lower respiratory tract infections.Methods： the object of this study is in a hospitah 120 patients with lower respiratory tract infection were selected, the clinical data were retrospectively an alyzed, and the patie nts in formed consent by the clinicians to take systematic random sampling method is divided into the observation group and the control group.Given given to the control group were treated with roxithromycin drugs for clinical treatment, giving patients in the observation group were treated with Cefoperazone / sulbactam drug.Results： the total effective number of observation group was 58 cases, accounting for 96.66%.The total effective cases in the control group were 45 cases, accounting for 75%.The differenee between the observation group and the control group in the total effective number of cases has statistical significanee (Plt;0.05) .Conclusion： in view of the lower respiratory tract infection patients, were treated with Cefoperazone / sulbactam to clinical symptoms effectively alleviate and improve resistance, can be widely used in clinical medicine. [keyword] cefoperazone sulbactam in lower respiratory tract infection下呼吸道感染是医学临床中较为常见的一种感染性疾病，下呼吸道感染通常情况下包括急性气管炎症，诸如支气管炎、慢性支气管炎以及肺炎等, 下呼吸道感染疾病主要是由于病毒、支原体和细菌等微生物感染而引起的，临床表现为咳嗽、胸痛等⑴。随着社会经济文化的不断进步，医疗卫生事业得到显著发展，目前医学临床中治疗下呼吸道感染的药物普遍采用头孑包哌酮/舒巴坦进行治疗，并能够取得一定疗效。本研究为探讨头砲哌酮/舒巴坦治疗下呼吸道感染的效果，选择120例患者采取不同的方法进行治疗，现报道如下。1资料与方法1.1 一般资料选取某院2014年4月?2015年4月收治的120例下呼吸道感染患者作为研究对象，在患者知情同意下由临床医师采取等距随机抽样法分为观察组和对照组。其